In today's Pharmaceutical Executive Daily, AlzeCure Pharma announces a collaboration with QuantumCell ApS worth more than $2.2 billion for global rights to its Neurostore platform including ...

An FDA panel voted 9-0 that the benefits of Moderna’s mRNA-1010 flu vaccine outweigh risks for adults aged 50 and older.

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

U.S. vaccine maker Moderna (MRNA) is exploring investments in manufacturing facilities in Germany and is particularly interested in acquiring sites that rival BioNTech (BNTX) plans to shut down as ...

Older adults who face the highest rates of flu hospitalization moved one step closer to a new vaccine option on June 18, 2026 ...

Police have now revealed the altercation that happened at Elizabeth Grove on Sunday morning sparked two pursuits. Police were called to a Main North Rd house just before 8am following a disturbance, ...

All right. We're just about at time. So let's keep moving with our next session with Merck. I'm very excited to have Rob Davis, CEO; and Dean Li, EVP Research Labs. Thank you both for being with us ...

Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia In oncology, a team-based approach ...

The comeback is in full swing. Financial and Valuation Metrics Moderna has cash, equivalents and short-term investments of $5.21 billion. They burned $1.6 billion in the TTM period, which gives them a ...

Health Care Bogus surgeon Felipe Hoyos-Foronda is expected to receive a five-to-15-year prison sentence after pleading guilty ...

dHarvard Immigration and Refugee Clinical Program, Harvard Law School, Harvard University, Boston, MA, USA eFrancois-Xavier Bagnoud Center for Health and Human Rights, Harvard University, Boston, MA, ...